Latest Articles

According to FutureWise analysis the market for Minimally Invasive Spine Technologies in 2026 is US$ 4.85 billion, and is expected to reach US$ 9.73 billion by 2036 at a CAGR of 7.21%. This growth is fueled by the rising prevalence of degenerative spine disorders, a preference for minimally invasive procedures, and advancements in navigation and implant technology. These technologies reduce tissue disruption, shorten hospital stays, and lead to faster recovery, making them popular among surgeons and patients. Minimally Invasive Spine Technologies have transformed the diagnosis and treatment of spinal disorders by enabling effective surgical interventions with reduced trauma to surrounding tissues. These technologies are designed to treat a wide range of spinal conditions, including degenerative disc disease, spinal stenosis, herniated discs, vertebral fractures, and spinal deformities. By utilizing smaller incisions, specialized instruments, and advanced imaging guidance, minimally ... Continue reading →

According to FutureWise analysis, the Mobile C-Arm market in 2026 is US$1.83 billion, and is expected to reach US$2.49 billion by 2036 at a CAGR of 3.13%.  The global Mobile C-Arm market is experiencing significant growth, driven by an increasing demand for minimally invasive surgical procedures that require real-time imaging. This trend is particularly evident in fields such as orthopedics, cardiovascular care, and pain management. Advances in flat-panel detector systems have greatly improved image quality and diagnostic accuracy while reducing radiation exposure for both patients and medical staff. As the geriatric population expands, there is a heightened need for orthopedic and trauma surgeries, with mobile C-arms providing crucial support for enhanced intraoperative visualization. Additionally, emerging markets in the Asia-Pacific region and the Middle East are witnessing a rise in the adoption of these advanced imaging devices, as healthcare facilities modernize their ... Continue reading →

According to FutureWise analysis the market for Mitochondrial DNA in 2026 is US$ 0.38 billion, and is expected to reach US$ 0.79 billion by 2036 at a CAGR of 7.59%. Market growth is fueled by the rising applications of mitochondrial DNA analysis in genetic diagnostics, oncology, and forensics. The adoption of advanced sequencing technologies and growing research on mitochondrial dysfunction in aging and metabolic disorders also contribute to market expansion. Mitochondrial DNA (mtDNA) is a specialized type of genetic material located within mitochondria, the organelles responsible for energy production in eukaryotic cells. Unlike nuclear DNA, which is inherited from both parents, mtDNA is passed down almost exclusively from the mother and is characterized by a small, circular structure. It contains essential genes that are crucial for oxidative phosphorylation, the biochemical process that generates adenosine triphosphate (ATP), the primary energy currency of the cell. This unique ... Continue reading →

According to FutureWise's analysis, the mixed reality market in healthcare is projected to reach US$3.61 billion in 2026 and US$25.17 billion by 2036, with a CAGR of 21.43%.  The global mixed reality market in healthcare is on an exhilarating ascent, fueled by the rising embrace of immersive technologies in surgical planning, medical training, and patient education within hospitals and medical institutions. Imagine a world where students and healthcare professionals can hone their skills in risk-free virtual environments, practicing intricate procedures with lifelike anatomical models. This groundbreaking approach is revolutionizing medical education! In the realm of remote consultations and telemedicine, mixed reality technology is gaining remarkable traction, especially as the healthcare industry rapidly transforms through digital advancements. Major investments from tech giants and healthcare providers are driving innovation, with a focus on developing specialized ... Continue reading →

According to FutureWise analysis the Miscarriage Analysis Market in 2026 is US$ 4.10 billion, and is expected to reach US$ 7.52 billion by 2036 at a CAGR of 6.25%. Market growth is fueled by greater awareness of recurrent pregnancy loss, rising maternal age, and increased use of advanced genetic testing. Innovations in molecular diagnostics and non-invasive testing are enhancing diagnostic accuracy and promoting broader clinical adoption. Miscarriage analysis is a vital aspect of reproductive healthcare that seeks to identify the underlying causes of pregnancy loss, especially in cases of recurrent miscarriages. A miscarriage is generally defined as the spontaneous loss of a pregnancy before 20 weeks of gestation, resulting from a complex interplay of genetic, anatomical, hormonal, immunological, and environmental factors. The primary goal of miscarriage analysis is to provide clarity for both patients and healthcare providers by employing various diagnostic tools and laboratory ... Continue reading →

According to FutureWise analysis the market for miRNA tools and services in 2026 is US$ 0.57 billion, and is expected to reach US$ 2.21 billion by 2036 at a CAGR of 14.51%. The strong growth in miRNA research is driven by its expanding role in disease diagnostics, therapeutic development, and biomarker discovery, especially in oncology and genetic disorders. The rising use of advanced sequencing platforms and bioinformatics by academic and pharmaceutical institutions is further boosting market expansion. MicroRNA (miRNA) tools and services are essential for advancing the fields of molecular biology and genomics research. They facilitate the identification, analysis, and functional characterization of miRNAs—small, non-coding RNA molecules that play a significant role in regulating gene expression at the post-transcriptional level. miRNAs are involved in various biological processes, such as cell differentiation, proliferation, apoptosis, and immune responses. Due to their ... Continue reading →

According to FutureWise analysis, the mitomycin c market in 2026 is US$0.28 billion, and is expected to reach US$0.52 billion by 2036 at a CAGR of 6.29%.  The global market for mitomycin C is on an impressive upward trajectory, fueled by the rising prevalence of bladder cancer and other cancers where this powerful drug is an essential chemotherapeutic tool. Known for its effectiveness in intravesical therapy, mitomycin C is a cornerstone in the fight against non-muscle invasive bladder cancer, creating a steady demand in oncology centers worldwide. The recent influx of generic formulations has opened doors in emerging markets, particularly across the Asia-Pacific and Latin America regions, contributing significantly to the market's expansion. Meanwhile, North America and Europe continue to lead the way, supported by their advanced healthcare systems and high cancer diagnosis rates. As awareness of early cancer detection and treatment grows, so too does the momentum behind ... Continue reading →

According to FutureWise analysis the market for MiRNA Sequencing and Assay in 2026 is US$ 0.42 billion, and is expected to reach US$ 1.13 billion by 2036 at a CAGR of 10.40%. The rapid growth is fueled by the rising use of miRNA analysis in cancer research, biomarker discovery, and precision medicine, along with its adoption in academia and pharmaceuticals. Advances in next-generation sequencing and investments in genomics are also driving market expansion. miRNA sequencing is a high-throughput DNA sequencing technique specifically designed for microRNAs, distinguishing it from other RNA sequencing methods by focusing on small RNAs. This approach allows researchers to explore tissue-specific expression patterns, identify miRNA isoforms, investigate disease associations, and discover previously uncharacterized miRNAs. The expression of miRNAs is closely linked to processes such as epithelial-to-mesenchymal transition, BRCA mutations, immune response, and stem cell properties in ... Continue reading →

The Counter-IED (Improvised Explosive Device) market is experiencing significant growth within the defense sector, largely due to the evolving threat of terrorism. Governments and military organizations globally are making substantial investments in counter-IED technologies and solutions, which are essential for detecting, neutralizing, and mitigating the effects of improvised explosive devices. These devices, typically constructed from commonly available materials, represent a considerable risk to both military personnel and civilian populations. As a result, the demand for effective counter-IED strategies has become increasingly critical. Several factors contribute to this market's expansion. Notably, the rise in terrorist attacks worldwide has heightened governments' urgency to bolster their security capabilities, driving a demand for advanced detection and neutralization systems. The report also includes data on the overview of the competitive situation among different ... Continue reading →

According to FutureWise analysis the market for Minoxidil in 2026 is US$ 1.18 billion, and is expected to reach US$ 1.90 billion by 2036 at a CAGR of 4.88%. Market growth is fueled by the rising prevalence of hair loss conditions like androgenetic alopecia, increased awareness of personal grooming, and the availability of topical solutions. Ongoing product innovations, including foam and combination therapies for both men and women, further support demand. Minoxidil is a pharmaceutical compound with a well-documented history of use in treating hair loss and specific cardiovascular conditions. Initially developed as an oral antihypertensive agent, it was later discovered that minoxidil has the ability to stimulate hair growth as a side effect, leading to its reformulation as a topical treatment for hair loss. Currently, it is one of the most widely recognized and utilized therapies for androgenetic alopecia in both men and women. In dermatological applications, minoxidil functions by ... Continue reading →